# Xingyao Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xingyao-technology

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Website: www.galixir.com
- Latest round: Series A (Dec 29, 2020)
- Investors on record: 6

## About

Established in 2019 and based in Shenzhen, China, Xingyao Technology is a company that empowers drug research and development through artificial intelligence technology. It is a participant of Merck China Innovation Hub. 

The company mainly operates an artificial intelligence drug discovery platform, Pyxir™, which combines expertise in computational chemistry and medicinal chemistry. The platform includes modules such as molecular design, attribute prediction, virtual screening, and targeted optimization, providing coverage from target development to clinical full-process service of former drug candidate discovery.

## Funding rounds

- Series A, Dec 29, 2020 — DCM, 5Y Capital, BAI Capital, Gaorong Ventures, Source Code Capital, Redpoint China Ventures
- Angel, Jul 12, 2019 — Gaorong Ventures

## Investors

- Gaorong Ventures (https://capitalatlas.ai/funds/gaorong-ventures) — Angel, Series A
- DCM (https://capitalatlas.ai/funds/dcm) — Series A
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series A
- BAI Capital (https://capitalatlas.ai/funds/bai-capital) — Series A
- Source Code Capital (https://capitalatlas.ai/funds/source-code-capital) — Series A
- Redpoint China Ventures (https://capitalatlas.ai/funds/redpoint-china-ventures) — Series A